Journal
JCO Precision Oncology
Publication Date
4-1-2023
Volume
7
First Page
e2100489
Document Type
Open Access Publication
DOI
10.1200/PO.21.00489
Rights and Permissions
King DA, Smith AR, Pineda G, Nakano M, Michelini F, Goedegebuure SP, Thyparambil S, Liao WL, McCormick A, Ju J, Cioffi M, Zhang X, Hundal J, Griffith M, Grandori C, Pollastro M, Rosati R, Margossian A, Chatterjee P, Ainge T, Flory M, Ocampo P, Chen LM, Poultsides GA, Baron AD, Chang DT, Herman JM, Gillanders WE, Park H, Hoos WA, Nichols M, Fisher GA, Kuo CJ. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates. JCO Precis Oncol. 2023 Apr;7:e2100489. doi: 10.1200/PO.21.00489. Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
Recommended Citation
King, Daniel A; Goedegebuure, S Peter; Zhang, Xiuli; Hundal, Jasreet; Griffith, Malachi; Gillanders, William E; Park, Haeseong; and et al., "Complete remission of widely metastatic human epidermal growth factor receptor 2-amplified pancreatic adenocarcinoma after precision immune and targeted therapy with description of sequencing and organoid correlates." JCO Precision Oncology. 7, e2100489 (2023).
https://digitalcommons.wustl.edu/oa_4/1722
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
